Emergent BioSolutions Inc.NYSE: EBS

Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026

· Issued by Emergent BioSolutions Inc. via GlobeNewswire

Summary by 6ix AI

Emergent BioSolutions Inc., which makes products for health threats such as smallpox, anthrax and opioid overdose emergencies, will host a conference call on Wednesday, August 5, 2026, at 5:00 p.m. eastern time to discuss its financial results for the second quarter of 2026.

Key details

  • The call can be followed live by webcast through the Investors page of Emergent's website; telephone participants must register in advance and will receive a confirmation email with the dial-in number, a unique passcode and a registrant ID.
  • A replay of the call will be available on the Investors page of Emergent's website.

6ix AI wrote this summary from the release below and checked it against the release.

GAITHERSBURG, Md., July 22, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, August 5, 2026, at 5:00 p.m. eastern time to discuss the financial results for the second quarter of 2026.

Participants can access the conference call live via webcast and also by visiting the Investors page of Emergent's website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.

A replay of the call can be accessed from the Investors page of Emergent's website.

About Emergent BioSolutions
At Emergent, our mission is to protect and save lives. For over 25 years, we've been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today's health challenges and tomorrow's threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.

Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com

Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com

Emergent BioSolutions Inc. on 6ix

Story so far

Earlier from Emergent BioSolutions

Later from Emergent BioSolutions

All Emergent BioSolutions news releases